文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

神经元过度兴奋驱动神经纤维瘤病 1 型模型中中枢和外周神经系统肿瘤的进展。

Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.

机构信息

Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA.

Department of Dermatology, University of Texas, Southwestern, Dallas, TX, 75390, USA.

出版信息

Nat Commun. 2022 May 19;13(1):2785. doi: 10.1038/s41467-022-30466-6.


DOI:10.1038/s41467-022-30466-6
PMID:35589737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9120229/
Abstract

Neuronal activity is emerging as a driver of central and peripheral nervous system cancers. Here, we examined neuronal physiology in mouse models of the tumor predisposition syndrome Neurofibromatosis-1 (NF1), with different propensities to develop nervous system cancers. We show that central and peripheral nervous system neurons from mice with tumor-causing Nf1 gene mutations exhibit hyperexcitability and increased secretion of activity-dependent tumor-promoting paracrine factors. We discovered a neurofibroma mitogen (COL1A2) produced by peripheral neurons in an activity-regulated manner, which increases NF1-deficient Schwann cell proliferation, establishing that neurofibromas are regulated by neuronal activity. In contrast, mice with the Arg1809Cys Nf1 mutation, found in NF1 patients lacking neurofibromas or optic gliomas, do not exhibit neuronal hyperexcitability or develop these NF1-associated tumors. The hyperexcitability of tumor-prone Nf1-mutant neurons results from reduced NF1-regulated hyperpolarization-activated cyclic nucleotide-gated (HCN) channel function, such that neuronal excitability, activity-regulated paracrine factor production, and tumor progression are attenuated by HCN channel activation. Collectively, these findings reveal that NF1 mutations act at the level of neurons to modify tumor predisposition by increasing neuronal excitability and activity-regulated paracrine factor production.

摘要

神经元活动正在成为中枢和外周神经系统癌症的驱动因素。在这里,我们研究了具有不同发展神经系统癌症倾向的肿瘤易感性综合征神经纤维瘤病 1 (NF1) 小鼠模型中的神经元生理学。我们表明,具有致癌 Nf1 基因突变的小鼠的中枢和外周神经元表现出过度兴奋和增加分泌与活性相关的促肿瘤旁分泌因子。我们发现了一种由外周神经元以活性调节方式产生的神经纤维瘤原代因子 (COL1A2),它增加了 NF1 缺陷 Schwann 细胞的增殖,从而确定了神经纤维瘤受神经元活动的调节。相比之下,在缺乏神经纤维瘤或视神经胶质瘤的 NF1 患者中发现的 Arg1809Cys Nf1 突变的小鼠则不会表现出神经元过度兴奋或发展这些 NF1 相关肿瘤。易患肿瘤的 Nf1 突变神经元的过度兴奋是由于 NF1 调节的超极化激活环核苷酸门控 (HCN) 通道功能降低所致,因此神经元兴奋性、活性调节旁分泌因子产生和肿瘤进展可通过 HCN 通道激活而减弱。总的来说,这些发现表明 NF1 突变通过增加神经元兴奋性和活性调节旁分泌因子产生,在神经元水平上改变肿瘤易感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/5fffd09a79fe/41467_2022_30466_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/49e0fcdcb8c7/41467_2022_30466_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/65e7986052f1/41467_2022_30466_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/dbc100045926/41467_2022_30466_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/c14d85bfb9dd/41467_2022_30466_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/35b182f328f7/41467_2022_30466_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/612bbf058c47/41467_2022_30466_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/85baeacf6aac/41467_2022_30466_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/5fffd09a79fe/41467_2022_30466_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/49e0fcdcb8c7/41467_2022_30466_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/65e7986052f1/41467_2022_30466_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/dbc100045926/41467_2022_30466_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/c14d85bfb9dd/41467_2022_30466_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/35b182f328f7/41467_2022_30466_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/612bbf058c47/41467_2022_30466_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/85baeacf6aac/41467_2022_30466_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c23/9120229/5fffd09a79fe/41467_2022_30466_Fig8_HTML.jpg

相似文献

[1]
Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.

Nat Commun. 2022-5-19

[2]
NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.

Neuro Oncol. 2024-8-5

[3]
NF1 mutation drives neuronal activity-dependent initiation of optic glioma.

Nature. 2021-6

[4]
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.

Oncogene. 2001-1-4

[5]
Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.

Mol Cell Neurosci. 2011-8-26

[6]
Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.

Cancer Res. 2008-12-15

[7]
An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.

Sci Rep. 2017-3-3

[8]
PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.

Cancer Res. 2012-6-14

[9]
NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Hum Mol Genet. 2016-5-1

[10]
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.

Neurosurg Focus. 2010-1

引用本文的文献

[1]
Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications.

Signal Transduct Target Ther. 2025-6-2

[2]
Emerging mechanism and therapeutic potential of neurofibromatosis type 1-related nerve system tumor: Advancing insights into tumor development.

Neurooncol Adv. 2025-2-16

[3]
Cognition and behavior in neurofibromatosis type 1: report and perspective from the Cognition and Behavior in NF1 (CABIN) Task Force.

Genes Dev. 2025-5-2

[4]
Global, regional, and national burden of neuroblastoma and peripheral nervous system tumours in individuals aged over 60 from 1990 to 2021: a trend analysis of global burden of disease study.

J Health Popul Nutr. 2025-3-17

[5]
Neurofibromin Deficiency Alters the Patterning and Prioritization of Motor Behaviors in a State-Dependent Manner.

J Neurosci. 2025-4-16

[6]
Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.

Sci Rep. 2025-1-31

[7]
Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition.

Neuron. 2025-3-19

[8]
Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host.

Cancer Cell. 2025-1-13

[9]
Human single cell RNA-sequencing reveals a targetable CD8 exhausted T cell population that maintains mouse low-grade glioma growth.

Nat Commun. 2024-11-28

[10]
Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trial.

Dev Med Child Neurol. 2025-4

本文引用的文献

[1]
NF1 mutation drives neuronal activity-dependent initiation of optic glioma.

Nature. 2021-6

[2]
Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.

Acta Neuropathol Commun. 2021-1-7

[3]
Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.

J Clin Invest. 2021-1-4

[4]
Testing broad-spectrum and isoform-preferring HCN channel blockers for anticonvulsant properties in mice.

Epilepsy Res. 2020-12

[5]
Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.

Neuro Oncol. 2021-4-12

[6]
After loss in Schwann cells, inflammation drives neurofibroma formation.

Neurooncol Adv. 2019-11-22

[7]
Midkine activation of CD8 T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth.

Nat Commun. 2020-5-1

[8]
Human iPSC-Derived Neurons and Cerebral Organoids Establish Differential Effects of Germline NF1 Gene Mutations.

Stem Cell Reports. 2020-4-14

[9]
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis.

Nature. 2020-1-29

[10]
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders.

Annu Rev Pharmacol Toxicol. 2020-1-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索